Sylatron Drug Interactions
Currently displaying 4 drugs known to have a minor interaction with Sylatron (peginterferon alfa-2b).
- 38 major drug interactions
- 159 moderate drug interactions
- 4 minor drug interactions
Minor interactions with Sylatron (peginterferon alfa-2b)
Note: Showing generic names only.
C
D
E
Sylatron disease interactions
There are 20 disease interactions with Sylatron (peginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
More about Sylatron (peginterferon alfa-2b)
- Sylatron consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.